Heptromic. Genomic predictors and oncogenic drivers in hepatocellurlar carcinoma

  • Heptromic Genomic predictors and oncogenic drivers in hepatocellular carcinoma. Watch the video
  • Heptromic will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
  • Heptromic’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
  • Heptromic is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.


  • Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists

    Thomson Reuters lists the 3000 most important names of 21 fields in science and social sciences. There have been evaluated articles published in indexed journals in these fields between 2003 and 2013 and there have only been considered those that rank in the top 1% by citations for field and year indexed in the Web of Science, the so called Highly Cited Papers. Thus, the fact of belonging to this classification means that the work of these researchers is considered particularly important among his colleagues.

  • IDIBAPS participates in a 5.7M European project to improve knowledge on liver cancer

    The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researchers, participates in a European project to identify the molecular mechanisms that have a direct impact on the development of hepatocellular carcinoma (HCC). The HEP-CAR project will evaluate the role of these mechanisms in different liver diseases leading to HCC -the infection by hepatitis B and C, overweight or alcohol-. This research initiative, coordinated by the University of Freiburg and in which ten European academic centers are involved, is part of Horizon 2020, the European Comission framework programme for research and innovation, and it is endowed with a budget of 5.7 million euros, one of them corresponding to IDIBAPS.

    September 2015

More news



More events


Scientific Publications

More scientific publications

Heptromic Partners

IDIBAPS-Hospital Clínic Barcelona

Dr. Josep Maria Llovet

IDIBAPS-Hospital Clínic Barcelona


Project coordination. Genomic & kinome profiling.

Project led by: Idibaps

Copyright © 2010 - 2016 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.